The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The North America active pharmaceutical ingredients market reached a value of US$ 72.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Active pharmaceutical ingredient (API) refers to the biologically/synthetic active component of a finished pharmaceutical product. Chemical synthesis, recombinant DNA, fermentation, isolation and recovery from natural sources are some of the common processes opted for API production. API in a drug is precisely used for curing, diagnosis, mitigation or prevention of human health issues. In addition to this, it has direct effect in restoring, correcting or modifying physiological functions of the body. On account of this, API has wide applications in the pharmaceuticals industry pertaining to oncology, central nervous system disorders, diabetes, neurological disorders, cardiovascular, respiratory disorders, etc.
The North American active pharmaceutical ingredients market is currently being driven by several factors. Predominantly, the rising geriatric population and escalated exposure to chronic diseases such as cancer and diabetes have escalated the API demand in the region. Apart from this, the US Government has increased the overall healthcare expenditure propelling the market growth. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. Moreover, technological advancements of new generation of APIs also represent an important factor driving the market growth in the region.
IMARC Group’s latest report provides a deep insight into the North America active pharmaceutical ingredients market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the North America active pharmaceutical ingredients market in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North America active pharmaceutical ingredients market report, along with forecasts for growth at the regional and country level from 2021-2026. Our report has categorized the market based on drug type, manufacturer type, synthesis type and therapeutic application.
|Base Year of the Analysis||2020|
|Segment Coverage||Drug Type, Manufacturer Type, Synthesis Type, Therapeutic Application, Country|
|Countries Covered||United States, Canada, Mexico|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 2499
Five User License $ 3499
Corporate License $ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at